Superficial Cervical Plexus Block and Quality of Recovery After Thyroidectomy
Launched by YALE UNIVERSITY · Aug 14, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a specific type of pain relief called a superficial cervical plexus block, using a medication called bupivacaine, can help patients recover better after thyroid surgery. Researchers want to see if this method of pain control makes a noticeable difference in how patients feel on the first day after their operation compared to those who receive a similar procedure with a harmless saline solution instead of the medication.
To participate in this trial, you need to be at least 18 years old and scheduled for thyroid surgery. You’ll fill out a survey before the surgery and then, while you are under anesthesia, you will randomly receive either the bupivacaine block or the saline placebo. After your surgery, you’ll complete another survey about your recovery experience. It's important to note that this study is currently looking for participants, and everyone involved will need to understand the procedures and have access to a smartphone or computer for follow-up.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 years or older
- • American Society of Anesthesiologists Physical Status classification I-III
- • Provision of signed and dated informed consent form
- • Stated willingness to comply with all study procedures and availability for the duration of the study
- • Scheduled for thyroid surgery
- • Access to smartphone device or computer with internet connection and has an email address
- Exclusion Criteria:
- • Non-English speaking
- • American Society of Anesthesiologists Physical Status classification \> III
- • Have an intolerance or contraindication to the medications involved in the study
- • Undergoing repeat thyroid surgery
- • Undergoing surgery with planned neck dissection
- • Plan for admission post-operatively
- • Positive pregnancy test on day of surgery (for participants with child-bearing potential)
- • Refusal to participate
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported